PMEF
GILD icon

Point72 Middle East FZE’s Gilead Sciences GILD Stock Holding History

Point72 Middle East FZE’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-55,292
Closed -$4.41M – 1737
2023
Q1 		$4.59M Sell
55,292
-10,978
-17% -$909K 0.16% 170
2022
Q4 		$5.69M Buy
+66,270
New +$5.25M 0.25% 83

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Middle East FZE's GILD Position: Q2 2023 in Review

Point72 Middle East FZE sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 55,292 shares — an estimated $4.41M sold.

Point72 Middle East FZE first reported a position in GILD in Q4 2022 and held it in 2 quarters. The position peaked at $5.69M in Q4 2022. 1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

  • Point72 Middle East FZE reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 55,292 Gilead Sciences shares in Q2 2023, an estimated $4.41M.
  • Point72 Middle East FZE first reported a position in Gilead Sciences in Q4 2022 and held it in 2 quarters.
  • Point72 Middle East FZE's Gilead Sciences position peaked at $5.69M in Q4 2022.
  • 1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on Point72 Middle East FZE's 13F filing for Q2 2023, filed 14 Aug 2023.